All Rankings

Top Biotech Startups in San Diego 2026

Private biotechnology and genomics companies headquartered in San Diego, ranked by disclosed lifetime funding.

Known total funding for 73 of 100 ranked companies: $10.8B.

Showing top 100 matching companies · Ranked by total funding raised

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+States&cities=San+Diego&states=California&operatingStatus=active&sort=total_funding_raised&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant, private equity or debt financing; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant, Private Equity, Debt Financing are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
Abdera Therapeutics

Platform biotechnology company developing radiopharmaceuticals for cancer.

San Diego, United States11–50Biotech, Healthcare
Series ATotal funding$142.0MJan 2021
27
Serapha Bio

Serapha Bio develops SERP-01, a proprietary in vivo base editing program in a Phase 1/2 clinical ...

San Diego, United States1–10Biotech, Healthcare
Series ATotal funding$138.0MJun 2026
28
Sidewinder Therapeutics

Pioneering the next generation of large molecule precision therapeutics to deliver new life-savin...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$137.0M
29
Actio Biosciences

Clinical-stage biotech leveraging genetics and precision medicine to develop therapeutics targeti...

San Diego, United States11–50Biotech, Healthcare
Series BTotal funding$121.0MJun 2025
30
Cullgen

Cullgen uses its uSMITE technology to develop targeted protein degraders for cancer, inflammation...

San Diego, United States11–50Biotech, Healthcare
Series CTotal funding$121.0MMay 2023
31
Architect Therapeutics

Architect Therapeutics uses C-H bond activation chemistry to design and synthesize novel 3D small...

San Diego, United States11–50Biotech, Healthcare
Series BTotal funding$120.0MJan 2024
32
Biosplice Therapeutics

Biosplice Therapeutics develops investigational drugs such as lorecivivint to treat osteoarthriti...

San Diego, United States51–200Biotech, Healthcare
Series BTotal funding$120.0MApr 2021
33
Shinobi Therapeutics

Shinobi Therapeutics engineers immune-evasive iPSC-derived cell therapies for cancer and autoimmu...

San Diego, United States11–50Biotech, Therapeutics
Extension RoundTotal funding$119.0MAug 2024
34
Aardvark Therapeutics

Biotech company

San Diego, United States11–50Biotech, Healthcare
Series CTotal funding$114.0MMay 2024
35
MBrace Therapeutics

MBrace Therapeutics translates innovative antibody-drug conjugate discovery into transformative t...

San Diego, United States11–50Biotech, Healthcare
Series BTotal funding$114.0MNov 2023
36
G(
GluBio (格博生物)

GluBio Therapeutics is a pioneering TPD company dedicated to developing targeted protein degrader...

San Diego, United States11–50Biotech
Corporate RoundTotal funding$102.0MFeb 2026
37
AdCentRx Therapeutics

San Diego-based clinical-stage biotech creating antibody-drug conjugate therapies that combine bi...

San Diego, United States11–50Biotech
Series ATotal funding$101.0MJan 2024
38
IconOVir Bio

IconOVir Bio is a biotechnology company pioneering next-generation oncolytic virus therapies to t...

San Diego, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$97.2MJun 2024
39
Ansun Biopharma

Develops novel therapeutics for viral diseases using sialic acid biology expertise

San Diego, United States11–50Biotech
Series ATotal funding$85.0MMay 2018
40
Epirium Bio

Clinical-stage biopharmaceutical company developing therapeutics for mitochondrial function

San Diego, United StatesBiotech
Series ATotal funding$85.0MDec 2019
41
Lassen Therapeutics

Biotechnology company developing monoclonal antibodies targeting IL-11 receptor

San Diego, United States11–50Biotech
Series BTotal funding$85.0MDec 2023
42
Tentarix Biotherapeutics

Tentarix Biotherapeutics develops conditionally active multispecific biologics designed to reach ...

San Diego, United States11–50Biotech, Oncology
Series BTotal funding$85.0MSep 2023
43
Abzena

Abzena helps biotechnology and pharmaceutical innovators develop complex biologics and bioconjuga...

San Diego, United States501–1000Biotech, Drug Discovery
Growth EquityTotal funding$75.0MMar 2022
44
Encodia

Privately held biotechnology company bringing the power of sequencing to proteomics through its p...

San Diego, United States51–200Biotech
Series CTotal funding$75.0MJan 2021
45
Kumquat Biosciences

Kumquat Biosciences develops cancer medicines combining novel target drug molecules with immuno-o...

San Diego, United States11–50Biotech, Healthcare
Series ATotal funding$70.0MFeb 2021
46
Degron Therapeutics

Degron Therapeutics aims to become a global leader in the discovery and development of molecular ...

San Diego, United States51–200Biotech
Extension RoundTotal funding$62.0MMay 2026
47
Primmune Therapeutics

Primmune develops oral TLR7 agonist cancer immunotherapies that activate plasmacytoid dendritic c...

San Diego, United States1–10Biotech, Healthcare
Series BTotal funding$61.7MJan 2026
48
BioNano Genomics

Genomics platform

San Diego, United States201–500Biotech
Series CTotal funding$53.0MNov 2014
49
Arnatar Therapeutics

Clinical-stage biotech company developing RNA medicine using its DARGER platform for rare diseases.

San Diego, United States11–50Biotech, Healthcare
Series ATotal funding$52.0MApr 2024
50
Belharra Therapeutics

Belharra Therapeutics pursues drug discovery in immunology and oncology using a photoaffinity-bas...

San Diego, United States51–200Advanced Materials, Biotech
Series ATotal funding$50.0MJan 2023